FDA Inspection 786483 — Cargille-Sacher Laboratories Inc.

Cargille-Sacher Laboratories Inc. — FEI 2210661

The FDA completed an inspection of Cargille-Sacher Laboratories Inc. on Jun 8, 2012 in Cedar Grove, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 8, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Cedar Grove, NJ (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
311321 CFR 820.70(g)Equipment design and installation
315921 CFR 820.184DHR content
317221 CFR 820.198(c)Investigation of device failures
320721 CFR 820.50(b)Supplier notification of changes

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.